Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Current Leases (2016 - 2025)

Historic Current Leases for Ligand Pharmaceuticals (LGND) over the last 14 years, with Q3 2025 value amounting to $1.1 million.

  • Ligand Pharmaceuticals' Current Leases rose 215.76% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 215.76%. This contributed to the annual value of $1.3 million for FY2024, which is 20878.05% up from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Current Leases stood at $1.1 million for Q3 2025, which was up 215.76% from $1.1 million recorded in Q2 2025.
  • Ligand Pharmaceuticals' Current Leases' 5-year high stood at $5.4 million during Q1 2021, with a 5-year trough of $410000.0 in Q4 2023.
  • Over the past 5 years, Ligand Pharmaceuticals' median Current Leases value was $1.1 million (recorded in 2025), while the average stood at $1.5 million.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Current Leases plummeted by 8333.33% in 2021 and then surged by 20878.05% in 2024.
  • Over the past 5 years, Ligand Pharmaceuticals' Current Leases (Quarter) stood at $1.4 million in 2021, then tumbled by 49.4% to $715000.0 in 2022, then crashed by 42.66% to $410000.0 in 2023, then soared by 208.78% to $1.3 million in 2024, then fell by 13.98% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.1 million for Q2 2025, and $859000.0 during Q1 2025.